Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 1
2010 4
2012 2
2013 1
2014 2
2015 3
2016 3
2017 2
2018 2
2019 3
2020 9
2021 6
2022 3
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Co-option of Neutrophil Fates by Tissue Environments.
Ballesteros I, Rubio-Ponce A, Genua M, Lusito E, Kwok I, Fernández-Calvo G, Khoyratty TE, van Grinsven E, González-Hernández S, Nicolás-Ávila JÁ, Vicanolo T, Maccataio A, Benguría A, Li JL, Adrover JM, Aroca-Crevillen A, Quintana JA, Martín-Salamanca S, Mayo F, Ascher S, Barbiera G, Soehnlein O, Gunzer M, Ginhoux F, Sánchez-Cabo F, Nistal-Villán E, Schulz C, Dopazo A, Reinhardt C, Udalova IA, Ng LG, Ostuni R, Hidalgo A. Ballesteros I, et al. Among authors: nistal villan e. Cell. 2020 Nov 25;183(5):1282-1297.e18. doi: 10.1016/j.cell.2020.10.003. Epub 2020 Oct 23. Cell. 2020. PMID: 33098771 Free article.
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
Brandi P, Conejero L, Cueto FJ, Martínez-Cano S, Dunphy G, Gómez MJ, Relaño C, Saz-Leal P, Enamorado M, Quintas A, Dopazo A, Amores-Iniesta J, Del Fresno C, Nistal-Villán E, Ardavín C, Nieto A, Casanovas M, Subiza JL, Sancho D. Brandi P, et al. Among authors: nistal villan e. Cell Rep. 2022 Jan 4;38(1):110184. doi: 10.1016/j.celrep.2021.110184. Cell Rep. 2022. PMID: 34986349 Free PMC article.
Engineering Non-Human RNA Viruses for Cancer Therapy.
Tur-Planells V, García-Sastre A, Cuadrado-Castano S, Nistal-Villan E. Tur-Planells V, et al. Among authors: nistal villan e. Vaccines (Basel). 2023 Oct 20;11(10):1617. doi: 10.3390/vaccines11101617. Vaccines (Basel). 2023. PMID: 37897020 Free PMC article. Review.
The Many Ways to Deal with STING.
Coderch C, Arranz-Herrero J, Nistal-Villan E, de Pascual-Teresa B, Rius-Rocabert S. Coderch C, et al. Among authors: nistal villan e. Int J Mol Sci. 2023 May 20;24(10):9032. doi: 10.3390/ijms24109032. Int J Mol Sci. 2023. PMID: 37240378 Free PMC article. Review.
Oncolytic Virotherapy in Glioma Tumors.
Rius-Rocabert S, García-Romero N, García A, Ayuso-Sacido A, Nistal-Villan E. Rius-Rocabert S, et al. Among authors: nistal villan e. Int J Mol Sci. 2020 Oct 14;21(20):7604. doi: 10.3390/ijms21207604. Int J Mol Sci. 2020. PMID: 33066689 Free PMC article. Review.
Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells.
Calzada-Fraile D, Iborra S, Ramírez-Huesca M, Jorge I, Dotta E, Hernández-García E, Martín-Cófreces N, Nistal-Villán E, Veiga E, Vázquez J, Pasqual G, Sánchez-Madrid F. Calzada-Fraile D, et al. Among authors: nistal villan e. Nat Commun. 2023 Oct 25;14(1):6772. doi: 10.1038/s41467-023-42480-3. Nat Commun. 2023. PMID: 37880206 Free PMC article.
Oncolytic virotherapy in lung cancer.
Nistal-Villan E, Rius-Rocabert S, Llinares-Pinel F. Nistal-Villan E, et al. Int Rev Cell Mol Biol. 2023;379:221-239. doi: 10.1016/bs.ircmb.2023.05.004. Epub 2023 May 30. Int Rev Cell Mol Biol. 2023. PMID: 37541725
The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J. Gonzalez-Perez M, et al. Among authors: nistal villan e. Front Immunol. 2021 Mar 8;12:632478. doi: 10.3389/fimmu.2021.632478. eCollection 2021. Front Immunol. 2021. PMID: 33763077 Free PMC article. Review.
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.
Garcia-Donas J, Martínez-Urbistondo D, Velázquez Kennedy K, Villares P, Barquin A, Dominguez A, Rodriguez-Moreno JF, Caro E, Suarez Del Villar R, Nistal-Villan E, Yagüe M, Ortiz M, Barba M, Ruiz-Llorente S, Quiralte M, Zanin M, Rodríguez C, Navarro P, Berraondo P, Madurga R. Garcia-Donas J, et al. Among authors: nistal villan e. Front Immunol. 2023 Apr 18;14:1156603. doi: 10.3389/fimmu.2023.1156603. eCollection 2023. Front Immunol. 2023. PMID: 37143685 Free PMC article. Clinical Trial.
46 results